The turnover surged to an unprecedented $7.52 million, marking the highest in the history of Regal.
In order to cater to the demands of our customers, we strengthened our production capacity by proliferating reactor capacity up to 8KL.
Sales began to witness consistent growth every year, reaching new heights.
Construction of the manufacturing facilities at the new unit commenced after obtaining the necessary licenses. Additionally, the merger process was finalized and duly recorded under Regal Remedies Ltd.
Measures were taken to enhance the manufacturing capabilities of the current unit by procuring additional machinery and equipment.
Steps taken to standardize systems and processes (ISO & Other Licenses).
The acquisition of D. J. Fluorine, a fluorine-based manufacturing unit, resulted in an increase in Regal Remedies' manufacturing capabilities and overall strength.
The process of merging with Shayona Intermediates Pvt. Ltd. was initiated to venture into the manufacturing sector.
Sales and purchase operations were initiated from the Mumbai office.
Due to a positive response from investors, Regal Remedies Pvt. Ltd. was rebranded as Regal Remedies Ltd.